Corporate Membership

Join Us

Elevate Your Brand and Succeed with ACT

ACT maintains a highly visible, well-regarded presence in the toxicology community through educational programs, professional networking opportunities, and our scientific journal.

Corporate support is essential to the continued success of the College and the achievement of its goals, and the ACT corporate membership program is a highly visible way for companies with a vested interest in the field of toxicology to show their support for the vital work of the College. In return, ACT corporate members benefit by elevating their brand and credibility as an ACT partner.

Why Join Forces with ACT?

ACT is a leader in toxicology education, offering well-regarded resources:

  • Signature Webinars
  • ToxChats Podcasts
  • Education Courses
  • eLearning Seminars
  • Annual Meeting—CE Courses, Symposia, Exhibition
  • International Journal of Toxicology

Who We Are and Who You Reach

ACT members are professional scientists, postdocs, and students representing:

  • Pharmaceutical and Biotech Industries
  • Contract Research Organizations
  • Regulatory Agencies
  • Academia
  • Consulting Firms

Corporate Membership Packages

Choose from two distinct packages to elevate your brand and maximize your reach.

Corporate Partner ($3,500 per Year):

  • Five job postings ($995 value)
  • Enhanced listing with hyperlink in the membership Newsletter
  • Enhanced listing with your logo in an issue of International Journal of Toxicology
  • Recognition at the Annual Meeting
  • One blog post with your unique content in the ACTalks blog
  • One additional Exhibitor Priority Point for companies that also exhibit at the Annual Meeting, and Priority exhibit booth selection at the Annual Meeting
  • Logo on the ACT website home page
  • ACT Corporate Member logo for use on your company website
  • Enhanced listing on the ACT website with your logo, company description (30 words), and hyperlink to your company’s website

Corporate Contributor ($2,000 per Year):

  • Two job postings ($398 value)
  • Listing of company name in the membership Newsletter
  • Listing of company name in an issue of International Journal of Toxicology
  • Listing of company name with hyperlink on the ACT website
  • Recognition at the Annual Meeting

To take advantage of ACT Corporate Membership, please contact Karen Cook, 703.547.0875 ext. 1423.

2024 Corporate Members

ACT Corporate Members provide a sustained and important contribution to our success with their financial contributions, helping ACT pursue key strategic initiatives and deliver timely educational programs.

ACT Corporate Partners 2024

Altascience Logo

Altasciences is a drug development solution company offering a flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services. Altasciences’ integrated, full-service solutions include preclinical safety testing, clinical pharmacology and proof of concept, bioanalysis, program management, medical writing, biostatistics, and data management.

Learn more
JOINN-Biomere Logo

Biomere is a global, nonclinical CRO with locations on the east and west coast, and in China (JOINN). Our personal approach and drive to expedite research timelines, make us ideally suited to support our clients’ needs.

Learn more
Genentech Logo

Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.

Learn more
Inotiv

Expect More: more attention, insight and a superlative experience. Inotiv delivers a comprehensive and integrated range of right-size in vivo discovery and tox services, BioA, pathology, DMPK and consulting solutions essential to your success.

Learn more
Lilly Logo

Lilly unites caring with discovery to create medicines that make life better for people around the world.

Learn more
Lovelace Logo

Lovelace Biomedical is a preclinical contract research organization helping pharmaceutical and biotechnology companies advance their complex drug development studies, with multidisciplinary expertise in toxicology, gene therapy, infectious disease, medical countermeasures.

Learn more
Inotiv

Hope changes lives. We’re in relentless pursuit of scientific breakthroughs and revolutionary medicines that will create a healthier world for everyone.

Learn more
Regeneron Logo

Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. We consistently translate science into medicine, leading to nine FDA-approved treatments and numerous product candidates.

Learn more

ACT Corporate Contributors 2024

AbbVie
Learn more
Gilead Sciences, Inc.
Learn more
ITR Laboratories Canada Inc
Learn more
Sanofi U.S.
Learn more
TOP